Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies
- 29 November 2005
- journal article
- case report
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 77 (2) , 177-183
Abstract
In the follow-up of treated gliomas, CT and MRI can often not differentiate radionecrosis from recurrent tumor. The aim of this study was to assess the interest of functional imaging with 99mTc-MIBI SPECT in a large series of 201 examinations. MIBI SPECT were performed in 81 patients treated for brain gliomas. A MIBI uptake index was computed as the ratio of counts in the lesion to counts in the controlateral region. SPECT was compared to stereotactic biopsy in 14 cases, or in the others cases to imaging evolution or clinical course at 6 months after the last tomoscintigraphy Two hundred and one tomoscintigraphies were performed. One hundred and two scans were true positive, 82 scans were true negative. Six scans were false positive (corresponding to 3 patients): 2 patients with an inflammatory reaction after radiosurgery, 1 with no explanation up to now. Eleven scans were false negative (5 patients): 1 patient with a deep peri-ventricular lesion, 2 patients with no contrast enhancement on MRI, 2 patients with a temporal tumor. The sensitivity for tumor recurrence was 90%, specificity 91.5% and accuracy 90.5%. We studied separately low and high grade glioma: sensitivity for tumor recurrence was respectively 91% and 89%, specificity 100% and 83% and accuracy 95% and 87%. MIBI SPECT allowed the diagnose of anaplasic degenerence of low grade sometimes earlier than clinical (5 cases) or MRI signs (7 cases). Our results confirm the usefullness of MIBI SPECT in the follow-up of treated gliomas for the differential diagnosis between radiation necrosis and tumor recurrence.Keywords
This publication has 38 references indexed in Scilit:
- Enhanced Accuracy in Differential Diagnosis of Radiation Necrosis by Positron Emission Tomography-Magnetic Resonance Imaging Coregistration: Technical Case ReportNeurosurgery, 2000
- La tomoscintigraphie cérébrale au 99mTc-MIBI est-elle utile au diagnostic de récidive locale chez les patients atteints de gliomes malinsCancer/Radiothérapie, 1998
- The in Vivo Metabolic Pattern of Low-grade Brain Gliomas: A Positron Emission Tomographic Study Using 18F-fluorodeoxyglucose and11 C-L-methylmethionineNeurosurgery, 1997
- SPET imaging of intracranial tumours with 99Tcm-sestamibiNuclear Medicine Communications, 1995
- Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.American Journal of Roentgenology, 1994
- Tc-99m MIBI Brain SPECT in the Diagnosis of Recurrent GliomaClinical Nuclear Medicine, 1994
- Multidrug resistance gene (MDR1) expression in human brain tumorsJournal of Neurosurgery, 1991
- Use of thallium-201 SPECT to quantitate malignancy grade of gliomasJournal of Neurosurgery, 1989
- Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studiesAmerican Journal of Roentgenology, 1988
- A Single Photon Dynamic Computer Assisted Tomograph (DCAT) for Imaging Brain Function in Multiple Cross SectionsJournal of Computer Assisted Tomography, 1980